HU217611B - Új indolopirrolokarbazolszármazékok, ilyen vegyületeket tartalmazó gyógyászati készítmények és eljárás ezek előállítására - Google Patents
Új indolopirrolokarbazolszármazékok, ilyen vegyületeket tartalmazó gyógyászati készítmények és eljárás ezek előállítására Download PDFInfo
- Publication number
- HU217611B HU217611B HU9203754A HU9203754A HU217611B HU 217611 B HU217611 B HU 217611B HU 9203754 A HU9203754 A HU 9203754A HU 9203754 A HU9203754 A HU 9203754A HU 217611 B HU217611 B HU 217611B
- Authority
- HU
- Hungary
- Prior art keywords
- formula
- compound
- group
- alkyl
- hydrogen
- Prior art date
Links
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D487/00—Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, not provided for by groups C07D451/00 - C07D477/00
- C07D487/12—Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, not provided for by groups C07D451/00 - C07D477/00 in which the condensed system contains three hetero rings
- C07D487/14—Ortho-condensed systems
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07H—SUGARS; DERIVATIVES THEREOF; NUCLEOSIDES; NUCLEOTIDES; NUCLEIC ACIDS
- C07H19/00—Compounds containing a hetero ring sharing one ring hetero atom with a saccharide radical; Nucleosides; Mononucleotides; Anhydro-derivatives thereof
- C07H19/02—Compounds containing a hetero ring sharing one ring hetero atom with a saccharide radical; Nucleosides; Mononucleotides; Anhydro-derivatives thereof sharing nitrogen
- C07H19/04—Heterocyclic radicals containing only nitrogen atoms as ring hetero atom
- C07H19/044—Pyrrole radicals
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P35/00—Antineoplastic agents
Landscapes
- Chemical & Material Sciences (AREA)
- Organic Chemistry (AREA)
- Health & Medical Sciences (AREA)
- General Health & Medical Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- Medicinal Chemistry (AREA)
- Public Health (AREA)
- Genetics & Genomics (AREA)
- Molecular Biology (AREA)
- Biochemistry (AREA)
- Chemical Kinetics & Catalysis (AREA)
- General Chemical & Material Sciences (AREA)
- Engineering & Computer Science (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Pharmacology & Pharmacy (AREA)
- Animal Behavior & Ethology (AREA)
- Biotechnology (AREA)
- Veterinary Medicine (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Indole Compounds (AREA)
- Nitrogen Condensed Heterocyclic Rings (AREA)
- Saccharide Compounds (AREA)
- Silicon Polymers (AREA)
- Plural Heterocyclic Compounds (AREA)
- Agricultural Chemicals And Associated Chemicals (AREA)
- Preparation Of Compounds By Using Micro-Organisms (AREA)
Applications Claiming Priority (3)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
JP34191691 | 1991-11-29 | ||
JP6926992 | 1992-02-18 | ||
JP25730692 | 1992-09-01 |
Publications (2)
Publication Number | Publication Date |
---|---|
HUT65699A HUT65699A (en) | 1994-07-28 |
HU217611B true HU217611B (hu) | 2000-03-28 |
Family
ID=27300000
Family Applications (3)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
HU9203754A HU217611B (hu) | 1991-11-29 | 1992-11-27 | Új indolopirrolokarbazolszármazékok, ilyen vegyületeket tartalmazó gyógyászati készítmények és eljárás ezek előállítására |
HU9203754A HU9203754D0 (en) | 1991-11-29 | 1992-11-27 | New indolo-pyrrholo-carbazole derivatives |
HU95P/P00172P HU211254A9 (en) | 1991-11-29 | 1995-06-08 | Indolopyrrolocarbazole derivatives |
Family Applications After (2)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
HU9203754A HU9203754D0 (en) | 1991-11-29 | 1992-11-27 | New indolo-pyrrholo-carbazole derivatives |
HU95P/P00172P HU211254A9 (en) | 1991-11-29 | 1995-06-08 | Indolopyrrolocarbazole derivatives |
Country Status (27)
Country | Link |
---|---|
EP (1) | EP0545195B1 (ru) |
JP (1) | JP2629542B2 (ru) |
KR (1) | KR100275976B1 (ru) |
AT (1) | ATE130617T1 (ru) |
AU (1) | AU650376B2 (ru) |
BG (1) | BG61036B1 (ru) |
CA (1) | CA2083534C (ru) |
CZ (1) | CZ287304B6 (ru) |
DE (1) | DE69206242T2 (ru) |
DK (1) | DK0545195T3 (ru) |
DZ (1) | DZ1634A1 (ru) |
ES (1) | ES2079774T3 (ru) |
FI (1) | FI106864B (ru) |
GR (1) | GR3018527T3 (ru) |
HU (3) | HU217611B (ru) |
IL (1) | IL103844A (ru) |
MX (1) | MX9206847A (ru) |
MY (1) | MY114655A (ru) |
NO (1) | NO178929C (ru) |
NZ (1) | NZ245203A (ru) |
PL (1) | PL171468B1 (ru) |
RO (1) | RO113469B1 (ru) |
RU (1) | RU2117671C1 (ru) |
SA (1) | SA93130351B1 (ru) |
TW (1) | TW224469B (ru) |
WO (1) | WO1993011145A1 (ru) |
YU (1) | YU48963B (ru) |
Cited By (2)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US6855698B2 (en) | 2001-03-22 | 2005-02-15 | Bristol-Myers Squibb Company | Topoisomerase I selective cytotoxic sugar derivatives of indolopyrrolocarbazoles |
US7138377B2 (en) | 2000-10-06 | 2006-11-21 | Bristol-Myers Squibb Company | Topoisomerase inhibitors |
Families Citing this family (30)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
WO1995030682A1 (fr) * | 1994-05-09 | 1995-11-16 | Banyu Pharmaceutical Co., Ltd. | Derive d'indolopyrolocarbazole antitumoral |
PT760375E (pt) * | 1994-05-09 | 2004-04-30 | Banyu Pharma Co Ltd | Derivado de indolopiprolocarbazole anti-tumoral |
DE69531686T2 (de) * | 1994-06-13 | 2004-07-15 | Banyu Pharmaceutical Co., Ltd. | Glycosyltransferase kodierendes gen und seine verwendung |
AU3086495A (en) * | 1994-08-02 | 1996-03-04 | Banyu Pharmaceutical Co., Ltd. | Antitumor indolopyrrolocarbazoles |
US5594009A (en) * | 1994-10-14 | 1997-01-14 | Cephalon, Inc. | Fused pyrrolocarbazoles |
US5591855A (en) * | 1994-10-14 | 1997-01-07 | Cephalon, Inc. | Fused pyrrolocarbazoles |
US5475110A (en) * | 1994-10-14 | 1995-12-12 | Cephalon, Inc. | Fused Pyrrolocarbazoles |
US5705511A (en) * | 1994-10-14 | 1998-01-06 | Cephalon, Inc. | Fused pyrrolocarbazoles |
AU6836696A (en) * | 1995-09-05 | 1997-03-27 | Banyu Pharmaceutical Co., Ltd. | Antitumor indolopyrrolocarbazole derivatives |
US5616724A (en) * | 1996-02-21 | 1997-04-01 | Cephalon, Inc. | Fused pyrrolo[2,3-c]carbazole-6-ones |
DE69709407T2 (de) * | 1996-08-22 | 2002-05-29 | Bristol-Myers Squibb Co., Wallingford | Zytotoxischer aminozucker und verwandte zuckerderivate von indolopyrrolocarbazolen |
GB9811624D0 (en) * | 1998-05-29 | 1998-07-29 | Merck Sharp & Dohme | Therapeutic use |
US6013646A (en) * | 1998-07-02 | 2000-01-11 | Bayer Corporation | Indolocarbazole derivatives useful for the treatment of neurodegenerative diseases and cancer |
US6833373B1 (en) | 1998-12-23 | 2004-12-21 | G.D. Searle & Co. | Method of using an integrin antagonist and one or more antineoplastic agents as a combination therapy in the treatment of neoplasia |
US6858598B1 (en) | 1998-12-23 | 2005-02-22 | G. D. Searle & Co. | Method of using a matrix metalloproteinase inhibitor and one or more antineoplastic agents as a combination therapy in the treatment of neoplasia |
US6703373B1 (en) | 1999-09-10 | 2004-03-09 | Banyu Pharmaceutical Co., Ltd. | Indolopyrrolocarbazole derivatives and antitumor agents |
FR2801054B1 (fr) * | 1999-11-17 | 2003-06-13 | Adir | Nouveaux derives de 12,13-(pyranosyl)-indolo[2,3-a]pyrrolo [3,4-c]carbazole et 12,13-(pyranosyl)-furo[3,4-c]indolo [2,3-a]carbazole, leur procede de preparation et les compositions pharmaceutiques qui les contiennent |
US6790836B2 (en) | 2000-02-24 | 2004-09-14 | Banyu Pharmaceutical Co., Ltd. | Process for preparing indolopyrrolocarbazole derivatives, intermediates therefor, and preparation process of the intermediates |
US6677450B2 (en) | 2000-10-06 | 2004-01-13 | Bristol-Myers Squibb Company | Topoisomerase inhibitors |
US6610727B2 (en) | 2000-10-06 | 2003-08-26 | Bristol-Myers Squibb Company | Anhydro sugar derivatives of indolocarbazoles |
US6555677B2 (en) | 2000-10-31 | 2003-04-29 | Merck & Co., Inc. | Phase transfer catalyzed glycosidation of an indolocarbazole |
US6559299B2 (en) | 2001-03-29 | 2003-05-06 | Merck & Co., Inc. | Preparation and isolation of indolocarbazole glycosides |
UA80552C2 (en) * | 2002-03-26 | 2007-10-10 | Combined drug of the antitumoral derivative indolopyrrolocarbazole and other antitumoral agent and its application at cancer treatment | |
CA2398828A1 (en) | 2002-08-09 | 2004-02-09 | Merck & Co., Inc. | A pharmaceutical composition containing an indolopyrrolocarbazole derivative |
WO2005010017A1 (ja) * | 2003-07-24 | 2005-02-03 | Banyu Pharmaceutical Co., Ltd | インドロピロロカルバゾール誘導体及び抗腫瘍剤 |
JPWO2005026185A1 (ja) * | 2003-09-16 | 2006-11-16 | 萬有製薬株式会社 | 抗腫瘍性新規インドロピロロカルバゾール誘導体 |
US7241779B2 (en) * | 2003-12-23 | 2007-07-10 | Cephalon, Inc. | Fused pyrrolocarbazoles |
US7169802B2 (en) | 2003-12-23 | 2007-01-30 | Cephalon, Inc. | Fused pyrrolocarbazoles |
ES2326459B1 (es) | 2008-04-08 | 2010-05-28 | Universidad De Oviedo | Indolocarbazoles glicosilados, su procedimiento de obtencion y sus usos. |
MX2011005055A (es) | 2008-11-19 | 2011-05-31 | Cephalon Inc | Nuevas formas de un compuesto de indazolo [5,4-a]pirrolo[3,4-c]car bazol. |
Family Cites Families (4)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US4785085A (en) * | 1986-11-21 | 1988-11-15 | Bristol-Myers Company | Rebeccamycin analogs |
DE4005969A1 (de) * | 1990-02-26 | 1991-08-29 | Boehringer Mannheim Gmbh | Neue trisubstituierte pyrrole, verfahren zu ihrer herstellung sowie arzneimittel, die diese verbindungen enthalten |
CA2037596C (en) * | 1990-03-06 | 1995-07-18 | Kin Sing Lam | Rebeccamycin analog by bromide precursor feeding |
IL97233A (en) * | 1990-03-06 | 1995-03-30 | Bristol Myers Squibb Co | Analogs of rabamycin, their manufacture and pharmaceutical preparations containing them |
-
1992
- 1992-11-20 NZ NZ245203A patent/NZ245203A/en not_active IP Right Cessation
- 1992-11-22 DZ DZ920145A patent/DZ1634A1/fr active
- 1992-11-23 DE DE69206242T patent/DE69206242T2/de not_active Expired - Fee Related
- 1992-11-23 DK DK92119904.8T patent/DK0545195T3/da active
- 1992-11-23 EP EP92119904A patent/EP0545195B1/en not_active Expired - Lifetime
- 1992-11-23 CA CA002083534A patent/CA2083534C/en not_active Expired - Fee Related
- 1992-11-23 ES ES92119904T patent/ES2079774T3/es not_active Expired - Lifetime
- 1992-11-23 AT AT92119904T patent/ATE130617T1/de not_active IP Right Cessation
- 1992-11-23 IL IL103844A patent/IL103844A/xx not_active IP Right Cessation
- 1992-11-24 JP JP4336560A patent/JP2629542B2/ja not_active Expired - Fee Related
- 1992-11-25 MY MYPI92002167A patent/MY114655A/en unknown
- 1992-11-25 TW TW081109448A patent/TW224469B/zh active
- 1992-11-26 AU AU29637/92A patent/AU650376B2/en not_active Ceased
- 1992-11-27 MX MX9206847A patent/MX9206847A/es unknown
- 1992-11-27 YU YU102692A patent/YU48963B/sh unknown
- 1992-11-27 NO NO924593A patent/NO178929C/no not_active IP Right Cessation
- 1992-11-27 HU HU9203754A patent/HU217611B/hu not_active IP Right Cessation
- 1992-11-27 RU RU93050130A patent/RU2117671C1/ru not_active IP Right Cessation
- 1992-11-27 FI FI925422A patent/FI106864B/fi active
- 1992-11-27 RO RO93-01067A patent/RO113469B1/ro unknown
- 1992-11-27 PL PL92304729A patent/PL171468B1/pl not_active IP Right Cessation
- 1992-11-27 CZ CS19923508A patent/CZ287304B6/cs not_active IP Right Cessation
- 1992-11-27 HU HU9203754A patent/HU9203754D0/hu unknown
- 1992-11-27 WO PCT/JP1992/001549 patent/WO1993011145A1/en active Application Filing
- 1992-11-28 KR KR1019920022729A patent/KR100275976B1/ko not_active IP Right Cessation
-
1993
- 1993-01-30 SA SA93130351A patent/SA93130351B1/ar unknown
- 1993-07-20 BG BG97970A patent/BG61036B1/bg unknown
-
1995
- 1995-06-08 HU HU95P/P00172P patent/HU211254A9/hu unknown
- 1995-12-22 GR GR950403667T patent/GR3018527T3/el unknown
Cited By (2)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US7138377B2 (en) | 2000-10-06 | 2006-11-21 | Bristol-Myers Squibb Company | Topoisomerase inhibitors |
US6855698B2 (en) | 2001-03-22 | 2005-02-15 | Bristol-Myers Squibb Company | Topoisomerase I selective cytotoxic sugar derivatives of indolopyrrolocarbazoles |
Also Published As
Similar Documents
Publication | Publication Date | Title |
---|---|---|
HU217611B (hu) | Új indolopirrolokarbazolszármazékok, ilyen vegyületeket tartalmazó gyógyászati készítmények és eljárás ezek előállítására | |
FI86189B (fi) | Foerfarande foer framstaellning av terapeutiskt anvaendbara rebeccamycinanaloger. | |
WO1989007105A1 (en) | Staurosporin derivatives | |
CA2102782C (en) | 2-fluoro-2-substituted adeninyl arabinosides as anti-cancer agents | |
US5591842A (en) | Indolopyrrolocarbazole derivatives | |
US5552427A (en) | Glutaminase inhibitory compounds, compositions, and methods of use | |
EP1070068B2 (en) | Granulatimide derivatives for use in cancer treatment | |
US5589365A (en) | Process for producing glycosylated indolopyrrolocarbazole derivatives by culturing certain microorganisms | |
US5668271A (en) | Indolopyrrolocarbazole derivatives | |
WO1991018003A1 (en) | Antitumor be-13793c derivative | |
HU217551B (hu) | 6[(2-Hidroxi-etil)-amino-alkil]-5,11-dioxo-5,6-dihidro-11H-indén[1,2-c]izokinolin-származékok, valamint eljárás előállításukra, továbbá hatóanyagként e vegyületeket tartalmazó gyógyászati készítmények | |
US20010051638A1 (en) | Ethanol solvate of (-)-cis-2- (2-chlorophenyl)-5, 7-dihydroxy-8 [4R-(3S-hydroxy-1-M ethyl) piperidinyl} -4H-1-benzopyran-4-one | |
JP6071901B2 (ja) | 新規の抗菌化合物 | |
WO2000064918A1 (en) | METHOD FOR THE PRODUCTION OF 2-CHLORO-2'-DEOXYADENOSINE (CLADRIBINE) AND ITS 3,5-DI-O-p-TOLUOYL DERIVATIVE | |
EP3907221A1 (en) | Fluorine-containing substituted benzothiophene compound, and pharmaceutical composition and application thereof | |
US6686385B2 (en) | Anhydro sugar derivatives of indolocarbazoles | |
CN113583026B (zh) | 一类含有稠合三环结构的化合物 | |
CN116217561A (zh) | 一类具有二甲基异吲哚酮结构的新型激酶抑制剂及其制备方法和用途 | |
Zou et al. | Synthetic approaches to the guanosine and xanthosine analogs 5-amino-3-. beta.-D-ribofuranosylpyrazolo [3, 4-e][1, 3] oxazin-7-one and 3-. beta.-D-ribofuranosylpyrazolo [3, 4-e][1, 3] oxazine-5, 7-dione and studies of their antitumor potential | |
SK10372002A3 (sk) | Etanolový solvát (-)-cis-2-(2-chlórgenyl)-5,7-dihydroxy-8[4R- (3S-hydroxy-1-metyl)piperidinyl]-4H-1-benzopyran-4-ón hydrochloridu, spôsob jeho prípravy a farmaceutická kompozícia, ktorá ho obsahuje | |
CA2322790C (en) | Granulatimide derivatives for use in cancer treatment | |
CN117777197A (zh) | 一类含磷化合物及其制备和应用 | |
CN117800979A (zh) | 一类四氢苯并呋喃[2,3-c]吡啶类激酶抑制剂及其制备方法及用途 | |
PL172316B1 (en) | Method of obtaining novel derivatives of indolopyrrole carbazole | |
PL172609B1 (en) | Method of obtaining derivatives of indolopyrrolocarbasole |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
MM4A | Lapse of definitive patent protection due to non-payment of fees |